KENNEDY CAPITAL MANAGEMENT LLC - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 91 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q2 2014. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
KENNEDY CAPITAL MANAGEMENT LLC ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q3 2015$1,923,000
-59.2%
608,473
-23.5%
0.04%
-54.1%
Q2 2015$4,711,000
-73.6%
795,738
-52.3%
0.08%
-72.8%
Q1 2015$17,833,000
+16.3%
1,668,152
+2.1%
0.31%
+10.6%
Q4 2014$15,336,000
+207.9%
1,633,253
+151.8%
0.28%
+187.8%
Q3 2014$4,981,000
+66.9%
648,551
+95.1%
0.10%
+78.2%
Q2 2014$2,985,000332,3880.06%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q2 2014
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 2,484,649$7,330,0008.59%
Avoro Capital Advisors LLC 5,144,916$15,178,0005.23%
Broadfin Capital, LLC 6,090,829$17,968,0001.10%
Aisling Capital LLC 2,010,000$5,930,0001.02%
Healthcare Value Capital, LLC 150,000$443,0000.73%
ACUTA CAPITAL PARTNERS, LLC 434,300$1,281,0000.61%
WALL STREET ASSOCIATES 696,300$2,054,0000.58%
SEARLE & CO. 172,500$500,0000.48%
Elk Creek Partners, LLC 2,253,667$6,648,0000.47%
KOPP INVESTMENT ADVISORS LLC 315,293$931,0000.46%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders